225,000 Shares in Sabra Healthcare REIT, Inc. $SBRA Purchased by Greenland Capital Management LP

Greenland Capital Management LP bought a new stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the third quarter, Holdings Channel reports. The fund bought 225,000 shares of the real estate investment trust’s stock, valued at approximately $4,194,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of SBRA. Oppenheimer & Co. Inc. lifted its holdings in shares of Sabra Healthcare REIT by 1.7% in the third quarter. Oppenheimer & Co. Inc. now owns 33,984 shares of the real estate investment trust’s stock worth $633,000 after buying an additional 581 shares in the last quarter. State of Michigan Retirement System lifted its stake in Sabra Healthcare REIT by 1.1% in the 2nd quarter. State of Michigan Retirement System now owns 57,249 shares of the real estate investment trust’s stock worth $1,056,000 after purchasing an additional 600 shares in the last quarter. Amalgamated Bank boosted its holdings in Sabra Healthcare REIT by 0.6% in the 3rd quarter. Amalgamated Bank now owns 105,159 shares of the real estate investment trust’s stock valued at $1,960,000 after purchasing an additional 612 shares during the period. Fifth Third Bancorp grew its position in shares of Sabra Healthcare REIT by 20.5% during the 3rd quarter. Fifth Third Bancorp now owns 4,675 shares of the real estate investment trust’s stock valued at $87,000 after purchasing an additional 795 shares in the last quarter. Finally, Cherry Creek Investment Advisors Inc. grew its position in shares of Sabra Healthcare REIT by 4.4% during the 2nd quarter. Cherry Creek Investment Advisors Inc. now owns 19,074 shares of the real estate investment trust’s stock valued at $352,000 after purchasing an additional 802 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Price Performance

Shares of Sabra Healthcare REIT stock opened at $20.43 on Tuesday. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. The firm has a market capitalization of $5.15 billion, a PE ratio of 31.92, a price-to-earnings-growth ratio of 1.60 and a beta of 0.67. The business’s 50-day moving average price is $19.17 and its 200-day moving average price is $18.85. Sabra Healthcare REIT, Inc. has a 12 month low of $15.75 and a 12 month high of $20.70.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The firm had revenue of $201.35 million during the quarter, compared to analysts’ expectations of $201.97 million. During the same period in the prior year, the company earned $0.36 EPS. The firm’s quarterly revenue was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.9%. Sabra Healthcare REIT’s dividend payout ratio is 187.50%.

Wall Street Analysts Forecast Growth

SBRA has been the subject of several research analyst reports. Citigroup lifted their price objective on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, February 18th. Truist Financial lifted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a research report on Tuesday, January 20th. Cantor Fitzgerald upped their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 17th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Thursday, January 22nd. Finally, Wall Street Zen cut shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research note on Friday, January 23rd. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $21.70.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.